Prostate Neoplasms Completed Phase 2 Trials for Bortezomib (DB00188)

Also known as: Neoplasm, Prostate / Neoplasms, Prostate / Prostate Neoplasm

IndicationStatusPhase
DBCOND0031071 (Prostate Neoplasms)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00425503PS-341 Followed by Removal of Prostate for Those With Prostate CancerTreatment